ZUSDURI Trademark

Trademark Overview

On Thursday, February 27, 2025, a trademark application was filed for ZUSDURI with the United States Patent and Trademark Office. The USPTO has given the ZUSDURI trademark a serial number of 99059260. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Monday, June 8, 2026. This trademark is owned by UroGen Pharma Ltd.. The ZUSDURI trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and compositions for the treatment of bladder cancer
zusduri

General Information

Serial Number99059260
Word MarkZUSDURI
Filing DateThursday, February 27, 2025
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateMonday, June 8, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 7, 2025

Trademark Statements

Goods and Servicespharmaceutical preparations and compositions for the treatment of bladder cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 27, 2025
Primary Code005
First Use Anywhere DateFriday, July 25, 2025
First Use In Commerce DateFriday, July 25, 2025

Trademark Owner History

Party NameUroGen Pharma Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRa'anana 4365007
IL
Party NameUroGen Pharma Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRa'anana 4365007
IL

Trademark Events

Event DateEvent Description
Thursday, February 27, 2025NEW APPLICATION ENTERED
Thursday, February 27, 2025APPLICATION FILING RECEIPT MAILED
Thursday, February 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 1, 2025ASSIGNED TO EXAMINER
Friday, August 1, 2025NON-FINAL ACTION WRITTEN
Friday, August 1, 2025NON-FINAL ACTION E-MAILED
Friday, August 1, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 10, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 10, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 10, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 11, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 1, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 7, 2025PUBLISHED FOR OPPOSITION
Tuesday, October 7, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 2, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 20, 2026TEAS STATEMENT OF USE RECEIVED
Tuesday, May 5, 2026ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, May 23, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 20, 2026USE AMENDMENT FILED
Saturday, May 23, 2026STATEMENT OF USE PROCESSING COMPLETE
Monday, June 8, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, June 8, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

zusduri bladder cancer treatment compositions preparations pharmaceutical